REBECCA C RATHBURN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care RICHMOND, VA NPI 1881271963

General Payments — all program years on this page

$11,650.65

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 102
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $9,015.35 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $4,561.4112
Consulting Fee $2,320.001
Food and Beverage $2,133.9425

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $764.7216
2023 $1,870.5848
2024 $9,015.3538

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091967479 Ipsen Biopharmaceuticals, Inc $106.06 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100431393 Novo Nordisk Inc $117.93 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133182625 Genentech USA, Inc. $64.93 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133182631 Genentech USA, Inc. $585.00 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133182635 Genentech USA, Inc. $206.06 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133182639 Genentech USA, Inc. $138.64 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133182644 Genentech USA, Inc. $682.88 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133598174 Gilead Sciences, Inc. $2,320.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133657084 Gilead Sciences, Inc. $86.55 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657086 Gilead Sciences, Inc. $119.76 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657088 Gilead Sciences, Inc. $142.46 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657090 Gilead Sciences, Inc. $49.95 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657092 Gilead Sciences, Inc. $49.95 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657094 Gilead Sciences, Inc. $59.98 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657096 Gilead Sciences, Inc. $59.99 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657098 Gilead Sciences, Inc. $132.69 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657100 Gilead Sciences, Inc. $27.31 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133657102 Gilead Sciences, Inc. $129.51 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133709075 Gilead Sciences, Inc. $42.74 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133709077 Gilead Sciences, Inc. $66.67 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133709079 Gilead Sciences, Inc. $113.72 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133709081 Gilead Sciences, Inc. $23.74 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133709083 Gilead Sciences, Inc. $89.49 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133858384 Gilead Sciences, Inc. $555.42 11/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133858386 Gilead Sciences, Inc. $574.15 11/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133858388 Gilead Sciences, Inc. $820.95 11/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133858390 Gilead Sciences, Inc. $21.00 12/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137812126 Takeda Pharmaceuticals U.S.A., Inc. $190.30 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137812128 Takeda Pharmaceuticals U.S.A., Inc. $327.55 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137812130 Takeda Pharmaceuticals U.S.A., Inc. $638.74 09/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137812132 Takeda Pharmaceuticals U.S.A., Inc. $39.97 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137812134 Takeda Pharmaceuticals U.S.A., Inc. $23.99 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137812136 Takeda Pharmaceuticals U.S.A., Inc. $59.98 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137812138 Takeda Pharmaceuticals U.S.A., Inc. $36.56 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137812140 Takeda Pharmaceuticals U.S.A., Inc. $45.04 09/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137812142 Takeda Pharmaceuticals U.S.A., Inc. $55.45 09/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1153522517 Salix Pharmaceuticals, a division of Bausch Health US, LLC $85.24 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153663752 Salix Pharmaceuticals, a division of Bausch Health US, LLC $125.00 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.